🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this research study is to determine if TLK286 given in combi...
Status
Completed
Location
Little Rock Hematology Oncology
Start Date
2004-12
Trial ID
NCT00102973
Treatments Being Tested
The purpose of this study is to determine if TLK286(Telcyta) is more effect...
Status
Completed
Location
UAB CCC Clinical Studies Unit
Start Date
TBD
Trial ID
NCT00080340
Treatments Being Tested
The purpose of this study is to determine the effectiveness of TLK286 in th...
Status
Completed
Location
Arizona Cancer Center
Start Date
2002-07
Trial ID
NCT00040638
Treatments Being Tested
This is a dose-ranging, open-label, Phase 1-2a study of TLK286 in combinati...
Status
Completed
Location
M.D. Anderson Cancer Center
Start Date
2003-02
Trial ID
NCT00052065
Treatments Being Tested
The purpose of this trial is to study the efficacy and safety of the triple...
Status
Completed
Location
Bay Area Cancer Research Group
Start Date
2004-08
Trial ID
NCT00088556
Treatments Being Tested
This is a Phase 2 study to determine the efficacy and safety of canfosfamid...
Status
Completed
Location
Cancer Institute of New Jersey
Start Date
2010-06
Trial ID
NCT01148108
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2001-05
Trial ID
NCT00022347
Treatments Being Tested
The purpose of this study is to determine the effectiveness of TLK286 in tr...
Status
Completed
Location
Arizona Cancer Center
Start Date
2002-04
Trial ID
NCT00035841
Treatments Being Tested
The purpose of this study is to determine the effectiveness and safety of T...
Status
Completed
Location
USC/Norris Comprehensive Cancer Center
Start Date
2001-06
Trial ID
NCT00038428
Treatments Being Tested
The purpose of this research study is to determine if Telcyta® given in com...
Status
Terminated
Location
Desert Oasis Cancer Center
Start Date
2006-05
Trial ID
NCT00350948
Treatments Being Tested